Philadelphia Trust Co. decreased its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, HoldingsChannel reports. The fund owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s holdings in Quest Diagnostics were worth $597,000 as of its most recent […]